Adms stock price target

The stock has an average rating of “Hold” and a consensus price target of $13.69. Shares of ADMS stock opened at $2.89 on Wednesday. Adamas Pharmaceuticals has a fifty-two week low of $1.90 and a fifty-two week high of $7.78. The stock has a market cap of $79.55 million, a P/E ratio of -0.76 and a beta of 1.65.

Adamas Pharmaceuticals Inc (NASDAQ:ADMS) price target set ... Sep 17, 2018 · Today, HC Wainwright set its price target on Adamas Pharmaceuticals Inc (NASDAQ:ADMS) to $45.00 per share. There are 11 Buy Ratings, no Strong Buy Ratings, no Sell Ratings, no Hold Ratings on the ADMS Stock Quote of Adamas Pharma Check out our ADMS stock analysis, current ADMS quote, charts, and historical prices for Adamas Pharma stock Here’s Why Analysts Just Lifted Their Adamas Pharmaceuticals, Inc. Price Target Adamas Pharmaceuticals (NASDAQ:ADMS) Stock Price Up 7.4% ... A decline of 36% from the average daily volume of 483,971 shares. The stock had previously closed at $2.16. ADMS has been the topic of a number of analyst reports. Cantor Fitzgerald restated a “neutral” rating and issued a $7.00 target price (down previously from $8.00) on shares of Adamas Pharmaceuticals in a report on Tuesday, December 17th. Adamas Pharmaceuticals (NASDAQ:ADMS) Ratings | Benzinga

Find real-time ADMS - Adamas Pharmaceuticals Inc stock quotes, company profile, news and forecasts from CNN Business. ADMS - Adamas Pharmaceuticals Inc Stock quote - CNNMoney.com Markets

Adamas Pharmaceuticals, Inc. Common Stock (ADMS) Analyst ... Based on analysts offering 12 month price targets for ADMS in the last 3 months. The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00. Sign in to your Adamas Pharmaceuticals, Inc. Common Stock (ADMS) Stock ... Adamas Pharmaceuticals, Inc. Common Stock (ADMS) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. ADMS | Adamas Pharmaceuticals Inc. Analyst Estimates ... ADMS updated stock price target summary. Dow Jones, a News Corp company. News Corp is a network of leading companies in the worlds of diversified media, news, education, and information services.

Read what bloggers on Seeking Alpha are saying about Adamas Pharmaceuticals, Inc. (ADMS).

Adamas Pharmaceuticals Stock Forecast: down to 0.000001 ... Historical index on US Stock Market : C "Should I invest in Adamas Pharmaceuticals stock?" "Should I trade "ADMS" stock today?" According to our live Forecast System, Adamas Pharmaceuticals, Inc stock is a bad long-term (1-year) investment*. "ADMS" stock predictions are updated every 5 minutes with latest exchange prices by smart technical market analysis. ADMS Stock Quote - Adamas Pharmaceuticals, Inc. Common ...

ADMS updated stock price target summary. Dow Jones, a News Corp company. News Corp is a network of leading companies in the worlds of diversified media, news, education, and information services.

Find real-time ADMS - Adamas Pharmaceuticals Inc stock quotes, company profile, news and forecasts from CNN Business. ADMS - Adamas Pharmaceuticals Inc Stock quote - CNNMoney.com Markets Adamas Pharmaceuticals, Inc. (ADMS) Stock Forum ... Find the latest Adamas Pharmaceuticals, Inc. (ADMS) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.

Adamas Pharmaceuticals, Inc. (ADMS) Blog Posts | Seeking Alpha

Adamas Pharmaceuticals, Inc. [ADMS] Price Analysis: NASDAQ ... Jan 09, 2020 · Adamas Pharmaceuticals, Inc. [NASDAQ: ADMS] opened at $4.26 and closed at $4.16 a share within trading session on Jan 8, 2020. That means that the stock gained by 22.84% compared to the closing price from a day before, when the stock touched $5.11. Adamas Pharmaceuticals Inc (NASDAQ:ADMS) price target set ... Sep 17, 2018 · Today, HC Wainwright set its price target on Adamas Pharmaceuticals Inc (NASDAQ:ADMS) to $45.00 per share. There are 11 Buy Ratings, no Strong Buy Ratings, no Sell Ratings, no Hold Ratings on the ADMS Stock Quote of Adamas Pharma Check out our ADMS stock analysis, current ADMS quote, charts, and historical prices for Adamas Pharma stock Here’s Why Analysts Just Lifted Their Adamas Pharmaceuticals, Inc. Price Target

Mar 04, 2020 · The stock was given Underperform rating by Mizuho in its report released on March 05, 2019, the day when the price target on the stock was placed at 5. Mizuho was of a view that ADMS is Neutral in its latest report on November 05, 2018. BofA/Merrill thinks that ADMS is worth Neutral rating.